Biocon Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Biocon Biologics Receives Rs 555 Cr (USD 75 Million) CapitalInjection from ADQTransaction Values Biocon Biologics at ~USD 4.17 Billion".
Biocon Limited has informed the Exchange regarding a press release dated January 07, 2021, titled "Biocon Biologics Receives Rs 555 Cr (USD 75 Million) CapitalInjection from ADQTransaction Values Biocon Biologics at ~USD 4.17 Billion".